Impact of body mass index on disease progression and outcomes in patients with nonalcoholic fatty liver disease

Author:

Biswas Sagnik1,Vaishnav Manas1,Farooqui Naba2,Aggarwal Arnav1,Pathak Piyush1,Yadav Rajni3,Das Prasenjit3,Elhence Anshuman4,Goel Amit5,Mishra Ashwani Kumar67,Shalimar 1

Affiliation:

1. Department of Gastroenterology and Human Nutrition Unit, All India Institute of Medical Sciences , New Delhi, 110029 , India

2. Department of Internal Medicine, Mayo Clinic , Rochester, MN 55092 , United States

3. Department of Pathology, All India Institute of Medical Sciences , New Delhi 110029 , India

4. Department of Gastroenterology, All India Institute of Medical Sciences , Raipur 492099 , India

5. Department of Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences , Lucknow 226014 , India

6. Department of Psychiatry , National Drug Dependence and Treatment Centre, , New Delhi 110029 , India

7. All India Institute of Medical Sciences , National Drug Dependence and Treatment Centre, , New Delhi 110029 , India

Abstract

Abstract Background The relationship between body mass index (BMI) and outcomes in patients with nonalcoholic fatty liver disease (NAFLD) is not well defined. This study aimed to assess the presentations, outcomes, and development of liver-related events (LREs) and non-LREs in patients with NAFLD stratified by BMI. Methods Records of NAFLD patients from 2000–2022 were reviewed. Patients were categorized as lean (18.5–22.9 kg/m2), overweight (23–24.9 kg/m2), and obese (>25 kg/m2) based on BMI. Stage of steatosis, fibrosis, and NAFLD activity score were noted in the patients undergoing liver biopsy in each group. Results Out of 1051 NAFLD patients, 127 (12.1%) had normal BMI, 177 (16.8%) and 747 (71.1%) were overweight and obese, respectively. Median [interquartile range] BMI was 21.9 [20.6–22.5], 24.2 [23.7–24.6], and 28.3 [26.6–30.6] kg/m2 in each group, respectively. Prevalence of metabolic syndrome and dyslipidemia were significantly higher in the obese. Obese patients had significantly higher median [interquartile range] liver stiffness (6.4 [4.9–9.4] kPa) than overweight and lean subjects. A higher proportion of obese patients had significant and advanced liver fibrosis. At follow-up, there were no significant differences in the progression of liver disease, new LREs, coronary artery disease, or hypertension across the BMI groups. Overweight and obese patients were more likely to develop new-onset diabetes by follow-up. The mortality rates in the three groups were comparable (0.47, 0.68, and 0.49 per 100 person-years, respectively), with similar causes of death (liver-related vs non-liver-related). Conclusions Patients with lean NAFLD have similar disease severity and rates of progression as the obese. BMI is not a reliable determinant of outcomes in NAFLD patients. Key messages What is already known on this topic What this study adds How this study might affect research, practice, or policy

Publisher

Oxford University Press (OUP)

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3